Clinical implications of sustained dopaminergic stimulation

F. Stocchi, P. N. Patsalos, A. Berardelli, L. Barbato, A. Bonamartini, M. Manfredi, S. Ruggieri

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Fluctuations in motor performance are the major problems in chronic management of Parkinson's disease. Most of these fluctuations reflect the decline of levodopa availability. As a consequence, levodopa dosage might be increased and the interdose interval progressively shortened. The postsynaptic dopamine receptors at this point are exposed to a nonphysiologic shift in dopamine level, which may induce changes at the receptor site and contribute to the appearance of 'on-off' phenomena and dyskinesias. We compared a group of 18 patients treated for 60 consecutive months with continuous subcutaneous lisuride infusion with a group of 20 patients treated with conventional oral levodopa treatment. The clinical evaluations performed during the study showed in the lisuride group only a worsening of dyskinesias, whereas the other symptoms remained unchanged. In the other group the evaluation scores showed a significant worsening of all long-term treatment complications. The slow-release preparations of levodopa may ensure a more continuous dopaminergic stimulation than standard formulations. However, the use of these compounds is difficult in severely fluctuating patients because the lack of a plasma peak level usually leads to a very long delay before patients turn 'on.' We studied the pharmacokinetic and clinical effects of the two slow-release preparations of levodopa [Madopar HBS and Sinemet controlled-release (CR)] and a combination of Sinemet CR plus standard Sinemet in 13 fluctuating parkinsonian patients. The results of this study show that the combination of standard Sinemet and Sinemet CR ensures a more prolonged clinical effect with a very short latency to the 'on' phase.

Original languageEnglish
JournalClinical Neuropharmacology
Volume17
Issue numberSUPPL. 2
Publication statusPublished - 1994

Fingerprint

Levodopa
Lisuride
Dyskinesias
Subcutaneous Infusions
Dopamine Receptors
Parkinson Disease
Dopamine
Pharmacokinetics
levodopa drug combination carbidopa
Therapeutics

Keywords

  • 'On-off' phenomena
  • Levodopa
  • Motor performance
  • Parkinson's disease

ASJC Scopus subject areas

  • Clinical Neurology
  • Pharmacology (medical)
  • Neuroscience(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Stocchi, F., Patsalos, P. N., Berardelli, A., Barbato, L., Bonamartini, A., Manfredi, M., & Ruggieri, S. (1994). Clinical implications of sustained dopaminergic stimulation. Clinical Neuropharmacology, 17(SUPPL. 2).

Clinical implications of sustained dopaminergic stimulation. / Stocchi, F.; Patsalos, P. N.; Berardelli, A.; Barbato, L.; Bonamartini, A.; Manfredi, M.; Ruggieri, S.

In: Clinical Neuropharmacology, Vol. 17, No. SUPPL. 2, 1994.

Research output: Contribution to journalArticle

Stocchi, F, Patsalos, PN, Berardelli, A, Barbato, L, Bonamartini, A, Manfredi, M & Ruggieri, S 1994, 'Clinical implications of sustained dopaminergic stimulation', Clinical Neuropharmacology, vol. 17, no. SUPPL. 2.
Stocchi F, Patsalos PN, Berardelli A, Barbato L, Bonamartini A, Manfredi M et al. Clinical implications of sustained dopaminergic stimulation. Clinical Neuropharmacology. 1994;17(SUPPL. 2).
Stocchi, F. ; Patsalos, P. N. ; Berardelli, A. ; Barbato, L. ; Bonamartini, A. ; Manfredi, M. ; Ruggieri, S. / Clinical implications of sustained dopaminergic stimulation. In: Clinical Neuropharmacology. 1994 ; Vol. 17, No. SUPPL. 2.
@article{5a0b243adc1446298dd90d77e9f56b28,
title = "Clinical implications of sustained dopaminergic stimulation",
abstract = "Fluctuations in motor performance are the major problems in chronic management of Parkinson's disease. Most of these fluctuations reflect the decline of levodopa availability. As a consequence, levodopa dosage might be increased and the interdose interval progressively shortened. The postsynaptic dopamine receptors at this point are exposed to a nonphysiologic shift in dopamine level, which may induce changes at the receptor site and contribute to the appearance of 'on-off' phenomena and dyskinesias. We compared a group of 18 patients treated for 60 consecutive months with continuous subcutaneous lisuride infusion with a group of 20 patients treated with conventional oral levodopa treatment. The clinical evaluations performed during the study showed in the lisuride group only a worsening of dyskinesias, whereas the other symptoms remained unchanged. In the other group the evaluation scores showed a significant worsening of all long-term treatment complications. The slow-release preparations of levodopa may ensure a more continuous dopaminergic stimulation than standard formulations. However, the use of these compounds is difficult in severely fluctuating patients because the lack of a plasma peak level usually leads to a very long delay before patients turn 'on.' We studied the pharmacokinetic and clinical effects of the two slow-release preparations of levodopa [Madopar HBS and Sinemet controlled-release (CR)] and a combination of Sinemet CR plus standard Sinemet in 13 fluctuating parkinsonian patients. The results of this study show that the combination of standard Sinemet and Sinemet CR ensures a more prolonged clinical effect with a very short latency to the 'on' phase.",
keywords = "'On-off' phenomena, Levodopa, Motor performance, Parkinson's disease",
author = "F. Stocchi and Patsalos, {P. N.} and A. Berardelli and L. Barbato and A. Bonamartini and M. Manfredi and S. Ruggieri",
year = "1994",
language = "English",
volume = "17",
journal = "Clinical Neuropharmacology",
issn = "0362-5664",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 2",

}

TY - JOUR

T1 - Clinical implications of sustained dopaminergic stimulation

AU - Stocchi, F.

AU - Patsalos, P. N.

AU - Berardelli, A.

AU - Barbato, L.

AU - Bonamartini, A.

AU - Manfredi, M.

AU - Ruggieri, S.

PY - 1994

Y1 - 1994

N2 - Fluctuations in motor performance are the major problems in chronic management of Parkinson's disease. Most of these fluctuations reflect the decline of levodopa availability. As a consequence, levodopa dosage might be increased and the interdose interval progressively shortened. The postsynaptic dopamine receptors at this point are exposed to a nonphysiologic shift in dopamine level, which may induce changes at the receptor site and contribute to the appearance of 'on-off' phenomena and dyskinesias. We compared a group of 18 patients treated for 60 consecutive months with continuous subcutaneous lisuride infusion with a group of 20 patients treated with conventional oral levodopa treatment. The clinical evaluations performed during the study showed in the lisuride group only a worsening of dyskinesias, whereas the other symptoms remained unchanged. In the other group the evaluation scores showed a significant worsening of all long-term treatment complications. The slow-release preparations of levodopa may ensure a more continuous dopaminergic stimulation than standard formulations. However, the use of these compounds is difficult in severely fluctuating patients because the lack of a plasma peak level usually leads to a very long delay before patients turn 'on.' We studied the pharmacokinetic and clinical effects of the two slow-release preparations of levodopa [Madopar HBS and Sinemet controlled-release (CR)] and a combination of Sinemet CR plus standard Sinemet in 13 fluctuating parkinsonian patients. The results of this study show that the combination of standard Sinemet and Sinemet CR ensures a more prolonged clinical effect with a very short latency to the 'on' phase.

AB - Fluctuations in motor performance are the major problems in chronic management of Parkinson's disease. Most of these fluctuations reflect the decline of levodopa availability. As a consequence, levodopa dosage might be increased and the interdose interval progressively shortened. The postsynaptic dopamine receptors at this point are exposed to a nonphysiologic shift in dopamine level, which may induce changes at the receptor site and contribute to the appearance of 'on-off' phenomena and dyskinesias. We compared a group of 18 patients treated for 60 consecutive months with continuous subcutaneous lisuride infusion with a group of 20 patients treated with conventional oral levodopa treatment. The clinical evaluations performed during the study showed in the lisuride group only a worsening of dyskinesias, whereas the other symptoms remained unchanged. In the other group the evaluation scores showed a significant worsening of all long-term treatment complications. The slow-release preparations of levodopa may ensure a more continuous dopaminergic stimulation than standard formulations. However, the use of these compounds is difficult in severely fluctuating patients because the lack of a plasma peak level usually leads to a very long delay before patients turn 'on.' We studied the pharmacokinetic and clinical effects of the two slow-release preparations of levodopa [Madopar HBS and Sinemet controlled-release (CR)] and a combination of Sinemet CR plus standard Sinemet in 13 fluctuating parkinsonian patients. The results of this study show that the combination of standard Sinemet and Sinemet CR ensures a more prolonged clinical effect with a very short latency to the 'on' phase.

KW - 'On-off' phenomena

KW - Levodopa

KW - Motor performance

KW - Parkinson's disease

UR - http://www.scopus.com/inward/record.url?scp=0027945487&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027945487&partnerID=8YFLogxK

M3 - Article

C2 - 9358190

AN - SCOPUS:0027945487

VL - 17

JO - Clinical Neuropharmacology

JF - Clinical Neuropharmacology

SN - 0362-5664

IS - SUPPL. 2

ER -